Design and Development of Novel Floating Drug Delivery Systems


Year : 2024 | Volume : 01 | Issue : 02 | Page : 1-22
    By

    Urmila C Patel,

  • AmitKumar R. Dhankani,

  • Sunil P. Pawar,

  1. Student, Department of Pharmaceutics, P.S.G.V.P.Mandal’s College of Pharmacy, Shahada, Nandurbar, Maharashtra, India
  2. Assistant Professor, Department of Pharmaceutics, P.S.G.V.P.Mandal’s College of Pharmacy, Shahada, Nandurbar, Maharashtra, India
  3. Principal, P.S.G.V.P.Mandal’s College of Pharmacy, Shahada, Nandurbar, Maharashtra, India

Abstract

Recent advances in science and technology have greatly aided in the creation of novel drug delivery methods, especially in addressing physiological issues including irregular stomach emptying times and brief stomach residence periods. Long-term stomach absorption is the goal of gastro-retentive dosage forms (GRDF). Floating drug delivery systems, expanding or swelling systems, polymer-based bioadhesive systems, high-density systems, and other ways that postpone stomach emptying are just a few of the techniques that have been developed to do this. With an emphasis on the main floating mechanism utilized to accomplish stomach retention, this review attempts to gather contemporary literature. There are many advantages to sustained oral release of gastrointestinal dose forms, particularly for medications that act locally in the stomach and are absorbed in the upper regions of the gastrointestinal system. The review includes the physiology of the stomach, variables that affect the excipient’s ability to retain food after it has been consumed, and methods for creating both multi-unit and single-unit hydrodynamically balanced systems. It goes into great length about these systems’ classification, formulation, and evaluation in addition to discussing a few applications.

Keywords: Floating drug delivery systems, single unit, multiple units, evaluation in-vitro and in vivo, gastric residence time, Classification

[This article belongs to International Journal of Membranes ]

How to cite this article:
Urmila C Patel, AmitKumar R. Dhankani, Sunil P. Pawar. Design and Development of Novel Floating Drug Delivery Systems. International Journal of Membranes. 2024; 01(02):1-22.
How to cite this URL:
Urmila C Patel, AmitKumar R. Dhankani, Sunil P. Pawar. Design and Development of Novel Floating Drug Delivery Systems. International Journal of Membranes. 2024; 01(02):1-22. Available from: https://journals.stmjournals.com/ijm/article=2024/view=182464


References

  1. Gupta P, Gnanarajan PK, Kothiyal P. Floating drug delivery system: a review. Int J Pharma Res Rev. 2015;4(8):37–44.
  2. Shyama SK, Sivakumar R. Floating drug delivery system: an updated review. Int J Curr Pharm Clinical Res. 2014;4(3):150–3.
  3. Parmar PD, Pande S, Shah SH, Sonara N, Patel GH. Floating drug delivery system: a novel approach to prolong gastric retention. World J Pharmacy Pharm Sci. 2014;3(4):418–44.
  4. Veerareddy PR, Bajjuri S, Sanka K, Jukanti R, Bandari S, Ajmeru RK, et al. Formulation and evaluation of gastroretentive dosage form of ofloxacin. Stamford J Pharmaceut Sci. 2011;4(1):9–18.
  5. Nirmal J, Saisivam S, Peddanna C, Muralidharan S, Godwinkumar S, Nagarajan M. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chem Pharmaceut Bull. 2008;56(10):1455–8.
  6. Hamza YE, Aburahma MH. Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. Aaps Pharmscitech. 2009;10:1357–67.
  7. El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharmaceut. 2001;220(1–2):13–21.
  8. Sarojini S, Manavalan R. An overview on various approaches to gastroretentive dosage forms. Int J Drug Dev Res. 2012;4(1):1–3.
  9. KR V, Gangadhar M, Sandhya S, Banji D. Critical assessment pertaining to gastric floating drug delivery systems. Hygeia J D Med. 2013;5(1):41–58.
  10. Gaikwad VD, Yadav VD, Jadhav PD. Formulation and evaluation of bilayer floating matrix tablets for captopril. Int J Cur Pharm Rev Res. 2013;4(2):27–35.
  11. Reddy DS, Ganesh Kumar Gudas. Formulation and evaluation of floating tablets of esomeprazole. IJPAR. 2017;6(4):754–61.
  12. Srivastava A. A review article on floating drug delivery system used in treatment of the depression. Int J Sci Res Public (IJSRP). 2019;9(4):358–63.
  13. Reddy KS, Swain SK, Chowdary KP, Prasad SV. Optimization of valsartan SR floating tablet formulation by 22 factorial design and multiple regression technique. Int Res J Pharm Med Sci. 2018;1:11–5.
  14. Begum RF, Singh S, Prajapati B, Sumithra M, Patel RJ. Advanced targeted drug delivery of bioactive agents fortified with graft chitosan in management of cancer: a review. Curr Med Chem. 2024.
  15. Senthil A, Suresh Kumar P, Raju CH, Mohideen S. Formulation and evaluation of gastric oral floating tablet of glipizide. Int J Biol Pharmaceut Res. 2010;1(2):108–13.
  16. Sunil PH, Mourya A, Praveen Kanna, Sampath M. Design formulation and evaluation of gastroretentive floating tablets of stavudine. Int J Res Pharmacol Pharmacotherap. 2021;6(1):93–103. doi: https://doi.org/10.61096/ijrpp.v6.iss1.2017.93-103
  17. Viveksarathi K, Kannan K. Design and in vitro evaluation of gastroretentive floating drug delivery system of rosigilitazone maleate. J Pharmaceut Sci Res. 2013;5(8):166.
  18. Sohail K, Javaid Z, Hamid I, Sharif A, Akhtar MF, Raza M, et al. Formulation and evaluation of ranitidine floating tablets using different polymer combinations. J Toxicol Pharmaceut Sci. 2017;1(1):18–25.
  19. Shahzad Y, Ibrar N, Hussain T, Yousaf AM, Khan IU, Rizvi SA. Relevancy of nizatidine’s release from floating tablets with viscosity of various cellulose ethers. Sci. 2021;3(2):22.
  20. Hafeez A, Maurya A, Singh J, Mittal A, Rana L. An overview on floating microsphere: gastro retention floating drug delivery system (FDDS). J Phytopharma. 2013;2(3):1–2.
  21. Jeganath S, Shafiq KM, Mahesh PG, Kumar SS. Formulation and evaluation of non-effervescent floating tablets of linagliptin using low-density carriers. Drug Invent Today. 2018;10(3):322.
  22. Patel KS, Rao AN, Patel DR, Patel DM, Patel AB. Formulation and evaluation of gastroretentive floating tablets of quetiapine fumarate. J Drug Deliv Therap. 2021;11(3-S):65–73.
  23. Kumari SD, Vengatesh S, Elango K, Damayanthi RD, Deattu N, Christina P. Formulation and evaluation of floating tablets of ondansetron hydrochloride. Int J Drug Dev Res. 2012;4(4):265–74.
  24. Jain D, Verma S, Shukla SB, Jain AK, Jain P, Yadav P. Formulation and evaluation of gastroretentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs). J Chem Pharmaceut Res. 2010;2(4):935–78.
  25. Bhardwaj V, Harikumar SL. Floating drug delivery system: a review. Pharmacophore. 2013;4(1-2013):26–38.
  26. Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv. 2011;18(2):97–110.
  27. Valte YB, Sangale HA, Kathuria HS, Talele SG, Jadhav AG. Formulation and evaluation of gastro retentive extended release formulation of metformin hydrochloride. GSC Adv Res Rev. 2020;2(2):008–17.
  28. Patil M, Vidyasagar G, Patil VB. Formulation, optimization and evaluation of floating tablets clarithromycin. Int J Pharm Pharm Sci. 2015;7(5):320–6.
  29. Airemwen OC, Uhumwangho MU. Gastro-floating drug delivery systems-a review. Tropic J Nat Prod Res (TJNPR). 2017;1(3):105–9.
  30. Jagdale SC, Patil S, Kuchekar BS. Application of design of experiment for floating drug delivery of tapentadol hydrochloride. Comput Math Meth Med. 2013;2013(1):625729.
  31. Javaid MU, ul Ain Q, Tahir U, Shahid S. A summarized review about natural polymers role in floating drug delivery system and in-vivo evaluation studies. Int Curr Pharmaceut J. 2017;6(4):23–6.
  32. Mistry RB, Sheth NS. Formulation and evaluation of floating drug delivery system. Int J Pharma and bio sciences. 2011;2(1):571–80.
  33. Chauhan YS, Kataria U, Dashora A. Formulation and evaluation of floating tablet for indomethacin. J Drug Deliv Therapeut. 2018;8(4):338–45.
  34. Bidkar SJ, Shelke MM, Dama GY, Bidkar JS. Formulation and evaluation of telmisartan floating drug delivery system. World J Pharm Res. 2019;8(8):1019-1031.
  35. Shanmuga Priya P. Formulation and Evaluation of Gastroretentive Floating Matrix Tablets of Perindopril Erbumine (Doctoral dissertation, College of Pharmacy, Madurai Medical College, Madurai, Tamil Nadu, India).
  36. Meka VS, Kohila Vani A, Gudy PJ, Sheshala R. Development of gastroretentive floating tablets of diltiazem hydrochloride and its statistical optimization. Farmacia. 2016;64(4):572–80.
  37. Jennissen HP. Ubiquitin and the enigma of intracellular protein degradation. Europe J Biochem. 1995;231(1):1–30.
  38. Reddy VS. Formulation and evaluation of floating tablets of ciprofloxacin hydrochloride. Asia J Pharmaceut (AJP). 2018;12(02).
  39. Bellad K, Nanjwade B, Sarkar A, Srichana T, Shetake R. Development and evaluation of curcumin floating tablets. Pharm Anal Acta. 2020;12:622.
  40. Hooda A. Gastroretentive drug delivery systems: a review of formulation approaches. Pharma Innov. 2012;1(8).
  41. Puthoori H, Murthy TE, Kaushik A. Formulation and evaluation of floating tablets of niacin for sustained release. Asia J Pharmaceut (AJP). 2012;6(1).
  42. Ichikawa M, Watanabe S, Miyake Y. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. J Pharmaceut Sci. 1991;80(11):1062–6.
  43. Gu TH, Chen SX, Zhu JB, Song DJ, Guo JZ, Hou HM. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets. Zhongguo yao li xue bao= Acta Pharmacologica Sinica. 1992;13(6):527–31.
  44. Rouge N, Cole ET, Doelker E, Buri P. Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs. Pharmaceut Develop Tech. 1998;3(1):73–84.
  45. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Develop Indust Pharma. 2000;26(9):965–9.
  46. Sarawade A, Ratnaparkhi MP, Chaudhari S. Floating drug delivery system: an overview. Int J Res Develop Pharma Life Sci. 2014;3(5):1106–15.
  47. Choudhury A, Renthlei L, Dewan M, Ahmed R, Barakoti H, Dey BK. Floating drug delivery system: an outlook. J Appl Pharmaceut Res. 2019;7(3):01–8.
  48. Garg RG, Gupta GD. Progress in controlled gastroretentive delivery systems. Tropic J Pharmaceut Res. 2008;7(3):1055–66.
  49. Panda S, Sailada NS, Devi B, Pattnaik S, Maharana L. Design of floating drug delivery systems: an update on polymeric advancements with special reference from natural origin. Int J Pharm Sci Rev Res. 2016;39(1):125–32.
  50. Singh A, Malviya R, K Sharma P. Pulmonary drug delivery system: a novel approach for drug delivery. Curr Drug Therapy. 2011;6(2):137–51.
  51. Yu J, Chien YW. Pulmonary drug delivery: physiologic and mechanistic aspects. Crit Rev Therap Drug Carr Syst. 1997;14(4).
  52. Kamalakkannan V, Puratchikody A, Prasanth VV, Masilamani K. Enhancement of drugs bioavailability by floating drug delivery system-A review. Int J Drug Deliv. 2011;3(4):558.
  53. Deshpande AA, Shah NH, Rhodes CT, Malick W. Development of a novel controlled-release system for gastric retention. Pharmaceut Res. 1997;14:815–9.
  54. Patel DM, Patel MJ, Patel AN, Patel CN. Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine. Int J Pharmaceut Investig. 2011;1(4):247.
  55. Kaushik AY, Tiwari AK, Gaur A. Role of excipients and polymeric advancements in preparation of floating drug delivery systems. Int J Pharmaceut Investig. 2015;5(1):1.
  56. Singh PK. Bilayer and floating-bioadhesive tablets: innovative approach to gastroretension. J Drug Deliv Therapeut. 2011;1(1).
  57. Kumar MR, Satyanarayana B, Paladugu ND, Neerukondavamsi SM, Pasha SI, Vemireddy SP, et al. A comprehensive review on gastro retentive drug delivery system. Acta Chimica Pharmaceutica Indica. 2013;3(2):149–64.
  58. Lopes CM, Bettencourt C, Rossi A, Buttini F, Barata P. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharmaceut. 2016;510(1):144–58.
  59. Tamizharasi S, Rathi V, Rathi JC. Floating drug delivery system. Syst Rev Pharma. 2011;2(1).
  60. Jiang H, Tian R, Hu W, Jia Y, Yuan P, Wang J, et al. Formulation and evaluation of gastroretentive floating drug delivery system of dipyridamole. Drug Develop Indust Pharma. 2015;41(4):674–80.
  61. Pund SB, Bhagat VC, Deshmukh MT, Kardile DP, Shete RV. A review on floating multi-particulate drug delivery system. Res J Pharma Tech. 2021;14(7):3987–92.
  62. Patil DH, Malpure PS. Formulation and evaluation of gastroretentive floating alginate beads of lafutidine by ionotropic gelation method. World J Pharm Res. 2016;5:1070–86.
  63. Varshosaz J, Tavakoli N, Roozbahani F. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv. 2006;13(4):277–85.
  64. Tamizharasi S, Sivakumar T, Chandra RJ. International Journal of Drug Development & Research| July-September 2011| Vol. 3| Issue 3| ISSN 0975-9344| Available online http://www. ijddr. in Covered in Official Product of Elsevier, The Netherlands© 2010 IJDDR. Int. J. Drug Dev. & Res. 2011;3(3):242–51.
  65. Ramesh Babu J, Vidyadhara S, Basha A. Formulation and in vitro evaluation of ofloxacin as floating drug delivery system. Der Pharmacia Lettre. 2013;5(5):82–92.
  66. Brahmaiah B, Bhagath GP, Gudipati M. Formulation and evaluation of gastroretentive floating drug delivery system of metoprolol tartarate. Int J Life Sci Biotech Pharma Res. 2013;2(1):183–97.
  67. Pahwa R, Bisht S, Kumar V, Kohli K. Recent advances in gastric floating drug delivery technology: a review. Curr Drug Deliv. 2013;10(3):286–98.
  68. Bakhsh EM, Ismail M, Sharafat U, Akhtar K, Fagieh TM, Danish EY, Khan SB, Khan MI, Khan MA, Asiri AM. Highly efficient and recoverable Ag-Cu bimetallic catalyst supported on taro-rhizome powder applied for nitroarenes and dyes reduction. J Mater Res Technol. 2022;18:769-87.
  69. Shakya R, Thapa P, Saha RN. In vitro and in vivo evaluation of gastroretentive floating drug delivery system of ofloxacin. Asia J Pharmaceut Sci. 2013;8(3):191–8.
  70. Dongare PS, Darekar AB, Gondkar SB, Saudagar RB. Floating drug delivery system: a better approach. Int J Pharma Biol Sci. 2013;3(4):72–85.
  71. Gupta R, Tripathi P, Bhardwaj P, Mahor A. Recent advances in gastro retentive drug delivery systems and its application on treatment of pylori infections. J Analyt Pharmaceut Res. 2018;7(4):404–10.
  72. Kusuma D, Krishnan KS, Sri S, Sree V. Formulation and evaluation of floating microspheres of acebutolol. Int J Pharm Sci Rev Res. 2017;46:31–6.
  73. Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2010;25(2):79.
  74. Patil JM, Hirlekar RS, Gide PS, Kadam VJ. Trends in floating drug delivery systems. J Scient Indust Res. 2006;65(1):11–21.
  75. Patel NA, Shah S, Shah N. Review on : gastro-retentive floating drug delivery system for the treatment of H. pylori 2015;5(3):249–53.
  76. Tripathi J, Thapa P, Maharjan R, Jeong SH. Current state and future perspectives on gastroretentive drug delivery systems. Pharmaceutics. 2019;11(4):193.
  77. Devi P, Rajamanickam V. The recent developments on gastric floating drug delivery systems: an overview. Int J Pharm Tech Research. 2010;2:524–34.
  78. VenKateswarlu K, Chandrasekhar KB. Development and statistical optimization of sustained release gastro retentive floating tablets of cephalexin. Marmara Pharmaceut J. 2016;20(2):172–83.
  79. Priya VS, Roy HK, Jyothi N, Prasanthi NL. Polymers in drug delivery technology, types of polymers and applications. Sch Acad J Pharm. 2016;5:305–8.
  80. Bogdanova Popov B, Karapetkovska-Hristova V, Ahmad MA, Shariati MA. An overview on applications of guar gum in food systems to modify structural properties. Saudi J Med Pharm Sci. 2017;3(5):373–6.
  81. Meka VS, Liang VA, Wee PH, Dharmalingham SR, Sheshala R, Gorajana A. Preparation and in vitro characterization of non-effervescent floating drug delivery system of poorly soluble drug, carvedilol phosphate. Acta Pharmaceutica. 2014;64(4):485–94.
  82. Vasave VS. A review on: floating drug delivery system. World J Pharmaceut Res. 2023;12(2):641–69.
  83. Ganesh K, Archana D, Preeti K. Natural polymers in the development of floating drug delivery systems: a review. Int J Pharmaceut Life Sci. 2013;2(4):165–78.
  84. Gadge G, Sabale V, Khade A. Current approaches on gastro retentive drug delivery system: an overview. Int J Pharma Res Tech (IJPRT). 2019;9(2):16–28.
  85. Saxena A, Gaur K, Singh V, Singh RK, Dashora A. Floating microspheres as drug delivery system. Am J Pharma Pharmaceut Sci. 2014;1(2):27–36.
  86. Yadav V, Jadhav P, Salunkhe P, Nikam P, Matkar S. Formulation and evaluation of gastroretentive tablets of antiulcer drug. Asia J Pharm Clin Res. 2016;9(6):48–52.
  87. Sarawade A, Ratnaparkhi MP, Chaudhari S. Floating drug delivery system: an overview. Int J Res Develop Pharma Life Sci. 2014;3(5):1106–15.
  88. Shadab MD, Singh GK, Ahuja A, Khar RK, Baboota S, Sahni JK, et al. Mucoadhesive microspheres as a controlled drug delivery system for gastroretention. Syst Rev Pharma. 2012;3(1).
  89. Gupta P, Gnanarajan PK, Kothiyal P. Floating drug delivery system: a review. Int J Pharma Res Rev. 2015;4(8):37–44.
  90. Nasa P, Mahant S, Sharma D.. Int J Pharmacy and Pharm Sci. 2010;2(3):2–7.
  91. Patel SS, Ray S, Thakur RS. Formulation and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori. Acta Pol Pharm. 2006;63(1):53–61.
  92. Bajpai SK, Dubey S. Dynamic release of vitamin B2 from floating barium alginate beads for gastric delivery. J Macromol Sci Part A Pure Appl Chem. 2007;44(9):1005–11.
  93. Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPs PharmsciTech. 2009;10:220–6.
  94. Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro–in vivo evaluation in healthy human volunteers. Europe J Pharmaceut Biopharma. 2010;74(2):332–9.
  95. Vo AQ, Feng X, Morott JT, Pimparade MB, Tiwari RV, Zhang F, Repka MA. A novel floating controlled release drug delivery system prepared by hot-melt extrusion. Europe J Pharmaceut Biopharma. 2016;98:108–21.
  96. Gadad AP, Patil MB, Naduvinamani SN, Mastiholimath VS, Dandagi PM, Kulkarni AR. Sodium alginate polymeric floating beads for the delivery of cefpodoxime proxetil. J Appl Polym Sci. 2009;114(3):1921–6.
  97. Garg RG, Gupta GD. Progress in controlled gastroretentive delivery systems. Tropic J Pharmaceut Res. 2008;7(3):1055–66.
  98. Hoffman A, Stepensky D, Lavy E, Eyal S, Klausner E, Friedman M. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int J Pharmaceut. 2004;277(1–2):141–53.
  99. Jagdale SC, Agavekar AJ, Pandya SV, Kuchekar BS, Chabukswar AR. Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride. AAPS PharmSciTech. 2009;10:1071–9.
  100. Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905.
  101. Jain SK, Agrawal GP, Jain NK. Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. AAPS pharmscitech. 2006;7:E54–62.
  102. Mayavanshi AV, Gajjar SS. Floating drug delivery systems to increase gastric retention of drugs: a review. Res J Pharma Tech. 2008;1(4):345–8.
  103. Rathnanand M, Pannala S. Formulation and in vitro evaluation of floating pulsatile tablets of nizatidine for chronotherapy of ulcers. J Pharm Res. 2011;4(5):1388–90.
  104. Miyazaki S, Yamaguchi H, Yokouchi C, Takada M, Hou WM. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chem Pharmaceut Bull. 1988;36(10):4033–8.
  105. Kharia AA, Hiremath SN, Singhai AK, Omray LK, Jain SK. Design and optimization of floating drug delivery system of acyclovir. India J Pharmaceut Sci. 2010;72(5):599.
  106. Prajapati ST, Patel LD, Patel DM. Studies on formulation and in vitro evaluation of floating matrix tablets of domperidone. India J Pharmaceut Sci. 2009;71(1):19.
  107. Li DX, Kim JO, Oh DH, Lee WS, Hong MJ, Kang JY, et al. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery. Arch Pharma Res. 2009;32:127–32.
  108. Porwal A, Dwivedi H, Pathak K. Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy. Brazil J Pharmaceut Sci. 2017;53(03):e00173.
  109. Mukhi U, Mohanty S. Formulation and evaluation of floating tablets of cefuroxime axetil. Int J Pharma Pharmaceut Sci. 2013;5(4):156–61.
Regular Issue Subscription Review Article
Volume 01
Issue 02
Received 09/05/2024
Accepted 26/07/2024
Published 12/11/2024
Publication Time 187 Days
Total Visits: 241


Loading citations…